Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1926 of 5804
-
Behavioral therapy may beat medication for Hair-Pulling and Skin-Picking
Symptom relief OngoingThe goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacological agent, for BFRBs. 28 subjects with trichotillomania (TTM) or skin picking disorder (SPD) will receive 8 weeks of memantine treatment, followed by 8 weeks o…
Phase: PHASE2, PHASE3 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Birth control implant may tame sickle cell pain crises
Disease control OngoingThe objective of this study is to measure the acceptability and impact of the progestin implant on frequency of vaso-occlusive crises, quality of life, and hematologic parameters in women with SCD.
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a new drug help people with aspirin allergy, asthma, and nasal polyps?
Disease control OngoingThe overall aim of the study is to determine the clinical efficacy and mechanisms of action of anti-IL-4a (dupilumab) as treatment for patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Aspirin-Exacerbated Respiratory Disease (AERD).
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:12 UTC
-
Could a nasal spray strengthen bones in kids with autism?
Disease control Recruiting nowThis is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin on bone health in children with autism spectrum disorder, ages 6-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (30 IU, 2 times daily) for 12 mo…
Phase: PHASE2 • Sponsor: Elizabeth Austen Lawson • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New scan may replace costly imaging for prostate cancer patients
Knowledge-focused Recruiting nowLutetium-177 (177Lu) prostate-specific membrane antigen (177Lu-PSMA) is a radiolabelled small-molecule inhibitor that binds with high affinity to PSMA and delivers β particle radiation. \[177Lu\]Lu-PSMA-617 (Pluvicto) was approved by the U.S. Food and Drug administration (FDA) in…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Gut feeling: probiotic shows promise for anxiety relief
Symptom relief CompletedThe investigators designed this double blind randomized controlled study and will recruit 120 patients 20 to 65 years old, with DSM-5 generalized anxiety disorder or unspecified anxiety disorder. After clinical symptoms and psychological evaluation and blood sampling, a semi-stru…
Phase: NA • Sponsor: Mackay Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Robot hip assist lets lung patients walk farther
Symptom relief ENROLLING_BY_INVITATIONChronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide with disabling consequences. Many with a compromised respiratory system cannot support the metabolic energy demands of walking causing them to walk slowly and stop often. Those with CRD c…
Phase: NA • Sponsor: West Park Healthcare Centre • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Weekly growth hormone shot tested in thousands of kids
Disease control Recruiting nowIn order to further observe the long-term safety and effectiveness of real-world polyethylene glycol-recombinant human growth hormone(PEG-rhGH) treatment of GHD, idiopathic short stature, and SGA in children, explore and analyze the factors affecting the efficacy of PEG-rhGH and …
Sponsor: Beijing Children's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:04 UTC
-
AI helps doctors spot more polyps during colonoscopy
Diagnosis CompletedHigh-definition (HD) colonoscopy is the gold standard for early diagnosis and treatment of lower gastrointestinal neoplasms, with the adenoma detection rate (ADR) serving as a key quality indicator due to its inverse correlation with colorectal cancer incidence. ADR is influenced…
Phase: NA • Sponsor: Gian Eugenio Tontini • Aim: Diagnosis
Last updated Jun 26, 2026 16:05 UTC
-
Botox injection study aims to heal painful anal fissures
Disease control CompletedThe goal of this clinical trial is to evaluate the efficacy of botulinum toxin injection in treatment of patients with chronic anal fissures comparing between two doses of botulinum toxin injection focusing on healing rate, fissure pain, incontinence and return to daily activity.…
Phase: PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a multiple sclerosis drug help people with parkinsonism walk better?
Disease control CompletedThis single-center observational cohort study will be conducted at Tangdu Hospital, Fourth Military Medical University. Patients presenting parkinsonism and poor levodopa response will be enrolled, including insidious-onset vascular parkinsonism (VaP) and Parkinson-plus syndromes…
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Exercise as medicine: study tests whether group workouts boost mental health in hospitalized patients
Symptom relief ENROLLING_BY_INVITATIONMore research is needed to elucidate the impacts of physical activity interventions on short- and long-term activity and neuropsychiatric symptoms (NPS) in psychiatric inpatients and to support its advantageousness when compared to current standards of care. To investigate the im…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Can depression explain extreme daytime sleepiness? a sleep study investigates
Knowledge-focused Recruiting nowIndividuals who have disorders of hypersomnolence (excessive sleepiness) often report symptoms of depression. The goal of this study is to further understand of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward fu…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Scientists probe the brain's decision-making circuitry one neuron at a time
Knowledge-focused ENROLLING_BY_INVITATIONThe purpose of this research is to better understand how the human brain accomplishes the cognitive task of making goal-directed decisions. These investigations are critical to better understand human cognition and to design treatments for disorders of decision making and perform…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New shot shows promise for tough eczema cases
Symptom relief CompletedThe study is a multicenter clinical trial and is designed as a proof-of-concept study to evaluate the efficacy, safety, tolerability, PK, immunogenicity, and PD of BSI-045B following SC injections. The study will enroll patients with moderate to severe AD to receive the 300 mg t…
Phase: PHASE2 • Sponsor: Biosion, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Exercise program aims to ease chest pain in hidden heart condition
Disease control OngoingExercise CMD is a prospective single-center, open-label, parallel arms randomized controlled trial. This trial aims to assess the impact of cardiac rehabilitation on top of optimal medical therapy on patient-reported outcomes in subjects with coronary microvascular disease and n…
Phase: NA • Sponsor: CoreAalst BV • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Immune cells take on tough leukemia in early trial
Disease control CompletedThis is a phase 1, first-in-human (FIH), open-label, multicohort study to evaluate the safety, tolerability and preliminary efficacy of iPSC NK cells in patients with relapsed/refractory AML or AML Minimal Residual Disease (MRD).
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can special glasses stop Kids' eyesight from getting worse?
Disease control OngoingThe goal of this clinical trial is to test Novel spectacle lenses in myopic children. The main question it aims to answer are: safety and efficacy of the lenses. Participants will be asked to wear spectacles and participate in eye exams and questionnaires. Researchers will compar…
Phase: NA • Sponsor: HOYA Lens Thailand LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy for insomnia shows promise in sleep study
Symptom relief CompletedMedication is FDA approved. The objective of this project is to test the efficacy of solriamfetol for treating insomnia (alone and in combination with Cognitive Behavioral Therapy for Insomnia \[CBT-I\]). Ultimately, this study will test whether wake extension (regardless of how …
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Which Diet-Exercise combo works best for obesity? study tests keto, fasting, and flexitarian plans
Disease control CompletedThis study investigates the effects of different dietary strategies (ketogenic diet, intermittent fasting, and semi-vegetarian diet), alone or in combination with a structured home-based exercise program, on anthropometric, metabolic, and hormonal parameters in women with obesity…
Phase: NA • Sponsor: Firat University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC